Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le samedi 31 août 2019
Doi : 10.1016/j.therap.2019.07.004
Received : 29 January 2019 ;  accepted : 10 July 2019
Statin-associated myasthenia: A case report and literature review

Valérie Gras-Champel a, , Inès Masmoudi a, Benjamin Batteux a, Philippe-Edouard Merle b, Sophie Liabeuf a, Kamel Masmoudi a
a Regional pharmacovigilance centre, division of clinical pharmacology, Amiens university hospital, 80054 Amiens, France 
b Division of neurological electrophysiology, Amiens university hospital, 80054 Amiens France 

Corresponding author. Service de pharmacologie clinique, CHU Amiens Picardie, 1, rond point du Professeur Christian Chabrol, 80054 Amiens cedex 1, France.Service de pharmacologie clinique, CHU Amiens Picardie1, rond point du Professeur Christian ChabrolAmiens cedex 180054France

Keywords : Statin, Myasthenia gravis, Diplopia, Adverse event, Pharmacovigilance

 This case has been declared to regional pharmacovigilance centre of Amiens on 1st June 2018.

© 2019  Société française de pharmacologie et de thérapeutique@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline